Demographics of a Large International Population of Patients Affected by Leber's Hereditary Optic Neuropathy
- PMID: 31932089
- DOI: 10.1016/j.ophtha.2019.11.014
Demographics of a Large International Population of Patients Affected by Leber's Hereditary Optic Neuropathy
Abstract
Purpose: To study the demographics of Leber's hereditary optic neuropathy (LHON) using a large international database of people affected by LHON.
Design: Cross-sectional study.
Participants: One thousand five hundred seventeen people affected by LHON with a known pathogenic genetic mutation.
Methods: Self-reported genetic and demographic data were collected. The data were de-identified and then analyzed.
Main outcome measures: Leber's hereditary optic neuropathy mutation, gender, age at vision loss onset, and geographical region.
Results: The data showed that both females and males can experience symptom onset at any age. We found a 3:1 male-to-female ratio. Interestingly, at younger than 5 years and older than 45 years, the male-to-female ratio of those becoming affected was approximately 1:1. A dramatic peak in age at onset of vision loss was found among males between 14 and 26 years of age. Disease onset in females occurred across all age groups, without any comparable dramatic peak of onset age. This study found that 10% of individuals become affected with LHON after 50 years of age. According to the literature, we found that the m.11778, m.14484, and m.3460 mutations were the most common LHON point mutations in both males and females, with a similar age at onset distribution.
Conclusions: This was the largest study of LHON demographics to date. It showed that women carrying an LHON mutation are at higher risk of losing vision than is generally expected. Unlike the traditional 5:1 male-to-female ratio commonly reported in the literature, we found a 3:1 male-to-female ratio. Earlier studies may have harbored an ascertainment bias of overemphasizing the confirmation of this being a disease of young men. However, our data suggest that LHON is a disease that affects both females and males of all ages. This should prompt physicians to conduct genetic testing for LHON in all patients who meet the clinical criteria, regardless of whether they fit the demographics traditionally associated with the disease. Counseling about LHON should be offered to all maternal bloodline relatives, females and males of all ages, because they are at risk of sudden-onset legal blindness.
Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Frequency and spectrum of mitochondrial ND6 mutations in 1218 Han Chinese subjects with Leber's hereditary optic neuropathy.Invest Ophthalmol Vis Sci. 2014 Mar 6;55(3):1321-31. doi: 10.1167/iovs.13-13011. Invest Ophthalmol Vis Sci. 2014. PMID: 24398099
-
Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber's Hereditary Optic Neuropathy mutation carriers: a prospective cohort study.Orphanet J Rare Dis. 2021 Mar 11;16(1):127. doi: 10.1186/s13023-021-01724-5. Orphanet J Rare Dis. 2021. PMID: 33706792 Free PMC article.
-
Influence of mutation type on clinical expression of Leber hereditary optic neuropathy.Am J Ophthalmol. 2006 Apr;141(4):676-82. doi: 10.1016/j.ajo.2005.11.007. Am J Ophthalmol. 2006. PMID: 16564802
-
Progress in diagnosis and treatment of Leber's hereditary optic neuropathy.J Mol Med (Berl). 2024 Jan;102(1):1-10. doi: 10.1007/s00109-023-02389-2. Epub 2023 Nov 20. J Mol Med (Berl). 2024. PMID: 37982904 Review.
-
Treatment of Leber's hereditary optic neuropathy: theory to practice.Semin Ophthalmol. 2002 Mar;17(1):33-8. doi: 10.1076/soph.17.1.33.10288. Semin Ophthalmol. 2002. PMID: 15513454 Review.
Cited by
-
Leber Hereditary Optic Neuropathy: Support, Genetic Prediction and Accurate Genetic Counselling Enhance Family Planning Choices.Clin Exp Ophthalmol. 2025 Apr;53(3):292-301. doi: 10.1111/ceo.14493. Epub 2025 Feb 2. Clin Exp Ophthalmol. 2025. PMID: 39895156 Free PMC article. Review.
-
Ganglion Cell Complex Thickness and Visual Function in Chronic Leber Hereditary Optic Neuropathy.Invest Ophthalmol Vis Sci. 2024 Oct 1;65(12):4. doi: 10.1167/iovs.65.12.4. Invest Ophthalmol Vis Sci. 2024. PMID: 39365263 Free PMC article.
-
Leber's hereditary optic neuropathy: Update on current diagnosis and treatment.Front Ophthalmol (Lausanne). 2023 Jan 11;2:1077395. doi: 10.3389/fopht.2022.1077395. eCollection 2022. Front Ophthalmol (Lausanne). 2023. PMID: 38983564 Free PMC article. Review.
-
Prevalence of Leber hereditary optic neuropathy in the Community of Madrid (Spain), estimation with a capture-recapture method.Orphanet J Rare Dis. 2024 May 29;19(1):220. doi: 10.1186/s13023-024-03225-7. Orphanet J Rare Dis. 2024. PMID: 38811977 Free PMC article.
-
Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation.Ophthalmol Ther. 2023 Feb;12(1):401-429. doi: 10.1007/s40123-022-00611-x. Epub 2022 Nov 30. Ophthalmol Ther. 2023. PMID: 36449262 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
